Analysis of genomic pathogenesis according to the revised Bethesda guidelines and additional criteria-Reference-Cited by-同舟云学术

Analysis of genomic pathogenesis according to the revised Bethesda guidelines and additional criteria

Published:2020-09-22 Issue:1 Volume:147 Page:117-128
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Kim Jin Cheon^ORCID,Kim Jong Hwan,Ha Ye Jin,Kim Chan Wook,Tak Ka Hee,Yoon Yong Sik,Kwon Yi Hong,Roh Seon Ae,Cho Dong-Hyung,Kim Seon-Kyu,Kim Seon-Young,Kim Yong Sung

Funder

the National Research Foundation of Korea

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-020-03391-8.pdf

Reference34 articles.

1. Aithal A, Rauth S, Kshirsagar P, Shah A, Lakshmanan I, Junker WM, Jain M, Ponnusamy MP, Batra SK (2018) MUC16 as a novel target for cancer therapy. Expert Opin Ther Targets. 22(8):675–686. https://doi.org/10.1080/14728222.2018.1498845

2. An W, Yao S, Sun X, Hou Z, Lin Y, Su L, Liu X (2019) Glucocorticoid modulatory element-binding protein 1 (GMEB1) interacts with the de-ubiquitinase USP40 to stabilize CFLARL and inhibit apoptosis in human non-small cell lung cancer cells. J Exp Clin Cancer Res. 38(1):181. https://doi.org/10.1186/s13046-019-1182-3

3. Arakawa K, Hata K, Kawai K, Tanaka T, Nishikawa T, Sasaki K, Shuno Y, Kaneko M, Hiyoshi M, Emoto S, Murono K, Nozawa H (2018) Predictors for high microsatellite instability in patients with colorectal cancer fulfilling the revised Bethesda guidelines. Anticancer Res. 38(8):4871–4876. https://doi.org/10.21873/anticanres.12800

4. Cappell MS (2008) Pathophysiology, clinical presentation, and management of colon cancer. Gastroenterol Clin North Am. 37(1):1–24. https://doi.org/10.1016/j.gtc.2007.12.002

5. Chubb D, Broderick P, Dobbins SE, Frampton M, Kinnersley B, Penegar S, Price A, Ma YP, Sherborne AL, Palles C, Timofeeva MN, Bishop DT, Dunlop MG, Tomlinson I, Houlston RS (2016) Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer. Nat Commun. 22(7):11883. https://doi.org/10.1038/ncomms11883

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SH2D4A inhibits esophageal squamous cell carcinoma progression through FAK/PI3K/AKT signaling pathway;Cellular Signalling;2024-02

2. Integrated clustering signature of genomic heterogeneity, stemness and tumor microenvironment predicts glioma prognosis and immunotherapy response;Aging;2023-09-11

3. Structure, activity and function of the lysine methyltransferase SETD5;Frontiers in Endocrinology;2023-02-17

4. Association between the cashmere production performance, milk production performance, and body size traits and polymorphism of COL6A5 and LOC102181374 genes in Liaoning cashmere goats;Animal Biotechnology;2022-12-17

5. Systematic identification of biochemical networks in cancer cells by functional pathway inference analysis;Bioinformatics;2022-11-30